AKT1 and pancreatic neoplasm: In addition, the compound BRT modulates the AKT-FOXO1 signaling axis in human pancreatic cancer cells, decreasing the level of phospho-AKT and inducing nuclear accumulation of the transcription factor FOXO1 in AsPC-1 and Panc-1 pancreatic cancer cells [64].